WIDE MOAT STOCKS COMPARISON

Checking

 

Stock Comparison

Berkshire Hathaway Inc. vs Johnson & Johnson

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Berkshire Hathaway Inc.

BRK.B · New York Stock Exchange

Market cap (USD)$1.1T
Gross margin (TTM)—
Operating margin (TTM)—
Net margin (TTM)22.3%
SectorFinancials
IndustryInsurance
CountryUS
Data as of2026-08-23
83/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Berkshire Hathaway Inc.'s moat claims, evidence, and risks.

View BRK.B analysis

Johnson & Johnson

JNJ · New York Stock Exchange

Market cap (USD)$663.3B
Gross margin (TTM)70.5%
Operating margin (TTM)26.8%
Net margin (TTM)21.5%
SectorHealthcare
IndustryPharmaceuticals
CountryUS
Data as of2026-08-23
73/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Johnson & Johnson's moat claims, evidence, and risks.

View JNJ analysis

Comparison highlights

  • Moat score gap: Berkshire Hathaway Inc. leads (83 / 100 vs 73 / 100 for Johnson & Johnson).
  • Segment focus: Berkshire Hathaway Inc. has 10 segments (28.3% in Insurance (underwriting + investment income)); Johnson & Johnson has 2 segments (64.7% in Innovative Medicine).
  • Moat breadth: Berkshire Hathaway Inc. has 13 moat types across 4 domains; Johnson & Johnson has 3 across 2.

Primary market context

Berkshire Hathaway Inc.

Insurance (underwriting + investment income)

Market

Insurance and reinsurance (property and casualty + life/health), including float-funded investing

Geography

Global

Customer

Consumers and businesses (policyholders) and insurers (reinsurance cedents)

Role

Underwriter and reinsurer plus investment manager of float

Revenue share

28.3%

Johnson & Johnson

Innovative Medicine

Market

Branded prescription pharmaceuticals (biopharma)

Geography

Global

Customer

Wholesalers, hospitals, retailers, healthcare professionals, payers

Role

Drug discovery, development, manufacturing, commercialization

Revenue share

64.7%

Side-by-side metrics

Berkshire Hathaway Inc.
Johnson & Johnson
Ticker / Exchange
BRK.B - New York Stock Exchange
JNJ - New York Stock Exchange
Market cap (USD)
$1.1T
$663.3B
Gross margin (TTM)
n/a
70.5%
Operating margin (TTM)
n/a
26.8%
Net margin (TTM)
22.3%
21.5%
Sector
Financials
Healthcare
Industry
Insurance
Pharmaceuticals
HQ country
US
US
Primary segment
Insurance (underwriting + investment income)
Innovative Medicine
Market structure
Competitive
Competitive
Market share
5.8% (reported)
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
83 / 100
73 / 100
Moat domains
Supply, Financial, Legal, Demand
Legal, Demand
Last update
2026-09-05
2026-09-05

Moat coverage

Shared moat types

Brand Trust

Berkshire Hathaway Inc. strengths

Scope EconomiesCost Of Capital AdvantageFloat PrepaymentCapacity MoatPhysical Network DensityConcession LicensePermits Rights Of WayDesign In QualificationCapex Knowhow ScaleScale Economies Unit CostDistribution ControlPreferential Input Access

Johnson & Johnson strengths

IP Choke PointTraining Org Change Costs

Segment mix

Berkshire Hathaway Inc. segments

Full profile >

Insurance (underwriting + investment income)

Competitive

28.3%

BNSF Railway (freight rail transportation)

Oligopoly

6.4%

Berkshire Hathaway Energy (regulated utilities, pipelines, renewables)

Monopoly

7.1%

Industrial products manufacturing (PCC, Lubrizol, IMC, Marmon, etc.)

Oligopoly

10.1%

Building products & housing (Clayton Homes, Shaw, Johns Manville, Benjamin Moore, etc.)

Competitive

7.3%

Consumer products manufacturing (Duracell, Forest River, apparel/footwear, toys, etc.)

Competitive

3.9%

Service businesses (FlightSafety, NetJets, TTI, Dairy Queen, etc.)

Competitive

6.2%

Retailing businesses (Berkshire Hathaway Automotive, home furnishings, jewelry, See's, etc.)

Competitive

5.3%

Pilot Travel Centers (travel centers + wholesale fuel marketing)

Oligopoly

11.5%

McLane (wholesale distribution to convenience stores and restaurants)

Oligopoly

13.8%

Johnson & Johnson segments

Full profile >

Innovative Medicine

Competitive

64.7%

MedTech

Oligopoly

35.3%

Act on this comparison

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.